NASDAQ:VERV

Verve Therapeutics, Inc. Stock Predictions

NASDAQ Stock Exchange > Healthcare > Biotechnology

Open Broker Account

$7.31

-0.290 (-3.82%)

At Close: Apr 15, 2024

Currently predicting for Wed, 17 Apr 2024

Trading levels for VERV

Fibonacci Support & Resistance Levels

		Level	Price
	Resistance	R3	7.99	9.30 %
		R2	7.76	6.17 %
		R1	7.62	4.23 %
Current price:			7.31
	Support	S1	7.16	-2.04 %
		S2	7.02	-3.98 %
		S3	6.79	-7.11 %

Accumulated Volume Support & Resistance Levels

		Level	Price
	Resistance	R3	8.71	19.15 %
		R2	8.32	13.82 %
		R1	8.01	9.58 %
Current price			7.31
	Support	S1	0	.
		S2	0	.
		S3	0	.

VERV Predictions History

2 months ago
n26ytrx8wp.411566 predicted that VERV for Jan. 24th is going

Rank:

9 months ago
PredictionBot.Kathy predicted that VERV for 2023-06-30 is going $18.32 (-2.29%)

9 months ago
PredictionBot.Warren predicted that VERV for 2023-06-30 is going $18.49 (-1.39%)

9 months ago
Bigmama predicted that VERV for 2023-06-30 is going

Rank:

About Verve Therapeutics, Inc.

Verve Therapeutics, Inc., a genetic medicines company, engages in developing gene editing medicines for patients to treat cardiovascular diseases. Its lead product candidate is VERVE-101, a single-course gene editing treatment that permanently turns off the PCSK9 gene in the liver. The company also engages in the development of ANGPTL3 program to permanently turn off the ANGPTL3 gene in the liver. It has a collaboration and license agreement with... VERV Profile

Golden Star

Ticker	Date	Change	Price
LXP	Apr 05	0.790%	$8.86
AKR	Apr 05	4.23%	$16.53
SARK	Mar 28	12.46%	$26.88
ARCC	Mar 25	0.596%	$20.12
STT	Mar 19	3.18%	$72.62
GGB	Mar 19	4.45%	$4.27
LNC	Mar 18	2.61%	$27.17
CAG	Mar 18	5.46%	$28.22
CMC	Mar 14	4.83%	$53.19
MASI	Mar 14	4.47%	$132.20

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by

Sign In